Yesterday the FDA changed the U.S. eligibility rules, as many had hoped they would:
The policy of determining eligibility by classes of people, rather than by individual risks, has ended.
From the Center for Biologics Evaluation & Research director:
This policy eliminates time-based deferrals and screening questions specific to men who have sex with men (MSM) and women who have sex with MSM. Under the final guidance issued today, all prospective blood donors will answer a series of individual, risk-based questions to determine eligibility.
The policy of determining eligibility by classes of people, rather than by individual risks, has ended.
From the Center for Biologics Evaluation & Research director:
"The implementation of these recommendations will represent a significant milestone for the agency and the LGBTQI+ community."